6-Methylmercaptopurine riboside

N/A

Report date: 2023/04/25 17:22:29
NME

Base Information

Drug Name6-Methylmercaptopurine riboside
Drug Alias Name6-甲基巯基嘌呤核糖核苷酸6-MMPRSQ-21977NSC-40774
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionPhosphoribosyl Amidotransferase inhibitors
TargetsPhosphoribosyl Amidotransferase
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFox Chase Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFox Chase Cancer Center
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A